Tzu-Hsuan Chiu

First- or second-generation epidermal growth factor receptor tyrosine kinase inhibitors in a large, real-world cohort of patients with non-small cell lung cancer

Allen Chung‐Cheng Huang, Chi‐Hsien Huang, Jia‐Shiuan Ju et al. · Therapeutic Advances in Medical Oncology · 2021 · 19 citations · Full text

Clinical outcomes and prognostic factors for prolonged mechanical ventilation in patients with acute stroke and brain trauma

Hung-Yu Huang, Chung-Shu Lee, Tzu-Hsuan Chiu et al. · Journal of the Formosan Medical Association · 2021 · 18 citations · Full text

Brain metastasis, EGFR mutation subtype and generation of EGFR-TKI jointly influence the treatment outcome of patient with EGFR-mutant NSCLC

Jia‐Shiuan Ju, Allen Chung‐Cheng Huang, Pi‐Hung Tung et al. · Scientific Reports · 2023 · 16 citations · Full text

Clinical and laboratory predictors for disease progression in patients with COVID-19: A multi-center cohort study

Shu‐Min Lin, Allen Chung‐Cheng Huang, Tzu-Hsuan Chiu et al. · Biomedical Journal · 2022 · 14 citations · Full text

The different overall survival between single-agent EGFR-TKI treatment and with bevacizumab in non-small cell lung cancer patients with brain metastasis

Tzu-Hsuan Chiu, Pi‐Hung Tung, Chi‐Hsien Huang et al. · Scientific Reports · 2022 · 11 citations · Full text